Hib-DTaP vaccine - Wyeth

Drug Profile

Hib-DTaP vaccine - Wyeth

Alternative Names: Hib-DTP-acellular vaccine - Wyeth Vaccines; Tetracel

Latest Information Update: 26 Jan 2001

Price : $50

At a glance

  • Originator Wyeth
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diphtheria; Haemophilus infections; Pertussis; Tetanus

Most Recent Events

  • 26 Jan 2001 Discontinued-preregistration for Haemophilus infections in USA (IM)
  • 26 Jan 2001 Discontinued-preregistration for Pertussis in USA (IM)
  • 26 Jan 2001 Discontinued-preregistration for Tetanus in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top